Liquid Biopsy Services
-
Manufactured by SAGA Diagnostics ABbased in SWEDEN
In direct comparisons, ctDNA has been shown to be superior to conventional serum protein biomarkers, circulating tumor cells, and radiographic imaging. Analysis of ctDNA in liquid biopsies is rapidly becoming one of the most important minimally invasive diagnostic methods used in oncology since it has overcome the many limitations of ...
-
Manufactured by Fluxion Biosciences Incbased in USA
Fluxion provides analytical services for a diverse range of liquid biopsy and CTC applications. Our Lab Services programs enables you to get results quickly and efficiently using Fluxion’s state-of-the-art technology and laboratory facilities. You design the study, we process and analyze the samples, you get the ...
-
based in USA
AmpliMark is the foundational technology behind Lucence’s liquid biopsy tests. AmpliMark uses unique molecular barcodes in this error-correction technology. It is designed to improve detection of multiple mutation types like single nucleotide variants, insertions and deletions (indels), copy number variations (CNVs), ...
-
by Karius, Inc.based in USA
The Karius Test is a liquid biopsy that can non-invasively and rapidly detect over 1000 pathogens causing both deep-seated and bloodstream infections from a single blood sample. The Karius Test helps clinicians avoid invasive, low-yield, and sequential diagnostic tests that can delay treatment for the most vulnerable hospitalized ...
-
by Biocollectbased in POLAND
, hormones, drugs, liquid biopsy, ...
-
Manufactured by Tethis S.p.Abased in ITALY
genetic sequencing on perfectly prepared samples allow maximum sensitivity and specificity of liquid biopsy tests in any clinical ...
-
based in INDIA
Strand has extensive experience in validating NGS-based panels under CAP- and CLIA-settings: be it germline panels, somatic tumor panels, or liquid biopsy panels, and be it small panels with tens of genes, to large panels with thousands of ...
-
Manufactured by BioMark Diagnostics Inc.based in CANADA
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck ...
-
based in USA
Our genomics laboratories in La Jolla, California (formerly Human Longevity Oncology), and Houston, Texas (formerly SeqWright Genomics), are outfitted for high throughput genomics. In addition to our molecular menu of validated assays spanning next-generation sequencing (NGS), DNA microarrays, qPCR/ddPCR, Sanger sequencing, NanoString, and ...
-
based in GERMANY
We combine leading scientific expertise in tumor immunology and virus-induced immune disorders with dedicated analytical know-how. Our services comprise Liquid Biopsy diagnostics with the analysis of virus-infected cells and the detection of disseminated tumor cells in blood, urine and other body fluids. Moreover, we offer the full ...
-
based in CANADA
alternative or complement to tissue assays. Plasma assays also provide the added potential for economical and minimally invasive serial sampling. Follow It is an amplicon-based focused liquid biopsy panel that analyzes cell-free circulating tumor DNA (ctDNA) in plasma isolated from peripheral blood. The assay is designed to detect SNVs and CNVs ...
-
Manufactured by Exosome Diagnostics, Inc.based in USA
Cells from healthy and diseased tissues shed billions of exosomes into the blood and other biofluids; the resulting total exosome content is the accumulation of exosomes contributed from all tissue. Only a fraction of these exosomes are derived from a specific cell or tissue ...
-
Manufactured by Co-Diagnostics, Inc.based in USA
Interested in using CoPrimers™ in your laboratory, enterprise, or research institution? The unique properties of CoPrimers™ make them ideally suited for a variety of applications where specificity is the key to optimal results, including multiplexing several targets, enhanced SNP detection, and library preparation for next-gen ...
-
Manufactured by Exosome Diagnostics, Inc.based in USA
Development of Known Biomarker(s) into a Targeted Assay. If a biomarker has already been identified it can become a shorter development path to a companion diagnostic (CDx). These biomarkers are typically used for patient stratification and to identify individuals likely to respond to particular therapeutics. ...
-
Manufactured by SAGA Diagnostics ABbased in SWEDEN
Cancer is caused by changes in a once-normal cell, which accumulates genetic damage and mutations in the cell’s “instruction book”, the DNA, causing the cell to grow and multiply uncontrollably. Today, we know much about the many mutations which can contribute to cancer, some mutations which can be inherited, as well as the many gene mutations which arise randomly and due to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you